The AETOS Shoulder System is part of the company’s upper extremity portfolio. Credit: Smith and Nephew / PRNewswire.

The US Food and Drug Administration (FDA) has granted 510(k) clearance for Smith+Nephew’s AETOS Shoulder System.

As part of the company’s upper extremity portfolio, the new system is intended for both anatomic and reverse total shoulder arthroplasty.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

It also complements the company’s sports medicine shoulder repair and biologics solutions.

AETOS System design surgeon Dr James Kelly said: “The AETOS Shoulder System was designed to be a cutting-edge press fit, bone conserving, convertible humeral stem.

“The system is designed for surgeons who desire maximum flexibility to reconstruct the humerus and glenoid, using an efficient and intuitive system that helps prioritise patient outcomes.”

See Also:

The system has been developed for restoring patients’ range of motion and reduction of arthritic shoulder pain.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

It comes with the AETOS Meta Stem, which helps maintain patient anatomy, maximise stability and preserve bone.

Designed to simplify the operating room flow, the system provides a compact and comprehensive portfolio of solutions that improve the surgical experience by facilitating intraoperative flexibility.

Smith+Nephew global orthopaedics president Brad Cannon said: “Receiving FDA clearance for the AETOS Shoulder System is a major milestone for Smith+Nephew.

“This platform is the culmination of years of research and development and represents our commitment to providing healthcare professionals with the best possible technology for their patients.”

Last month, Smith+Nephew secured an Innovative Technology contract from Vizient to distribute its PICO single-use negative pressure wound therapy (sNPWT) system, a portable, easy-to-use, canister-free system equipped with the company’s soft port technology.